Skip to main content
Log in

The use of telemedicine in combination with a new stroke-code-box significantly increases t-PA use in rural communities

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background: The benefit of tissue plasminogen activator (t-PA) is strongly associated with the time to treatment. In Bavaria, Germany, only half of the population has the opportunity to be transferred to 1 of the 19 stroke units within the critical time window of less than 3 hours. The aim of this study was to investigate the benefit of a new stroke-code-box for t-PA thrombolysis combined with a telemedicine network system to increase the use of acute stroke thrombolysis.

Methods: Two specialized stroke centers in Germany established a 24-hour telemedicine network (Telemedicine Pilot Project of an Integrated Stroke Care [TEMPiS]) to advise 12 community hospitals in eastern Bavaria. These clinics are linked via telemedicine in a 24-hour/7-day service network that allows patients to be examined by experts via a video-conference system Additionally, a special stroke-code-box for acute t-PA thrombolysis was designed to reduce time in the application and documentation process.

Results: In the 12-month period before implementation of the TEMPiS network system, 10 patients had received systemic thrombolysis. In our 6-month study period (from July to December 2003) and after implementation of a stroke-code-box for t-PA thrombolysis within the telestroke network, 164 patients with acute stroke were presented with t-PA treatment indications. Of this patient population, 27.4% (45 of 164) received t-PA.

Conclusions: Stroke care, including t-PA thrombolysis in non-urban areas, is feasible using a modern stroke unit concept within a telestroke network. With the expertise of specialized stroke centers accessed via telemedicine and the design of a stroke-code-box for t-PA thrombolysis, nearly one-third of patients presented with a possible indication for systemic thrombolysis can be treated with t-PA, thereby increasing the options for a successful stroke treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gage BF. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke 2000;31:822–827.

    PubMed  CAS  Google Scholar 

  2. Adams H, Brott T, Furlan A. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 1996;27:1711–1718.

    PubMed  Google Scholar 

  3. The National Institute of Neurological Disorders and Stroke TPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.

    Article  Google Scholar 

  4. Albers GW. Advances in intravenous thrombolytic therapy for treatment of acute stroke. Neurology 2001;57:77–81.

    Google Scholar 

  5. Levine SR, Gorman M. Telestroke: the application of telemedicine for stroke. Stroke 1999;30:464–469.

    PubMed  CAS  Google Scholar 

  6. Wang S, Lee SB, Pardue C, et al. Remote evaluation of acute ischemic stroke; reliability of National Institutes of Health Stroke Scale via telestroke. Stroke 2003;34:188–192.

    Article  Google Scholar 

  7. Johnston KC, Worrall BB. Teleradiology assessment of computerized tomographs online reliability study (TRACTORS) for acute stroke evaluation. Telemed J e-Health 2003;9:227–233.

    Article  PubMed  Google Scholar 

  8. Reponen J. Initial experience with a wireless personal digital assistant as a teleradiology terminal for reporting emergency computerized tomography scans. J Telemed Telecare 2000;6:45–49.

    Article  PubMed  CAS  Google Scholar 

  9. Handschu R, Littmann R, Reulbach U, et al. Telemedicine in emergency evaluation of acute stroke. Interrater agreement in remote video examination with a novel multimedia system. Stroke 2003;34:2842–2846.

    Article  PubMed  Google Scholar 

  10. Shafqat S, Kvedar JC, Guanci MM, Chang Y, Schwamm LH. Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke 1999;30(10):2141–2145.

    PubMed  CAS  Google Scholar 

  11. Wiborg A, Widder B, for the TESS Study Group. Teleneurology to improve stroke care in rural areas. The telemedicine in stroke in swabia (TESS) project. Stroke 2003;34:2957–2963.

    Article  Google Scholar 

  12. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers. JAMA 2000;283:3102–3109.

    Article  PubMed  CAS  Google Scholar 

  13. Audebert HJ, Kukla C, V. Clarenau St., et al. Telemedicine for safe and extended use of thrombolysis in stroke. Stroke 2005;36(2):287–291.

    Article  PubMed  CAS  Google Scholar 

  14. Chodroff PH. A three-year review of telemedicine at the community level clinical and fiscal results. J Telemed Telecare 1999;5:28–30.

    Article  Google Scholar 

  15. LaMonte MP, Bahouth M, Hu P, et al. Telemedicine for acute stroke. Triumphs and Pitfalls. Stroke 2003;34:725–728.

    Article  PubMed  CAS  Google Scholar 

  16. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice. A meta-analysis of safety data. Stroke 2003;34:2847–2850.

    Article  PubMed  CAS  Google Scholar 

  17. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283:1151–1158.

    Article  PubMed  CAS  Google Scholar 

  18. NINDS Symposium. Setting new directions for stroke care: rapid identification and treatment of stroke. Washington, D.C., December 12–13, 1996.

  19. Sillimann SL, Quinn B, Huggett V, Merino JG. Use of a field-to stroke center helicopter transport program to extend thrombolytic therapy to rural residents. Stroke 2003;34:729–733.

    Article  Google Scholar 

  20. Grotta J. Acute hospital care: resource utilisation. In: Marler J, Jones P, Emr M, eds. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. Arlington, Virginia: National Institute of Neurological Disorders and Stroke 1997, pp. 87–89.

    Google Scholar 

  21. Heuschmann PU, Berger K, Misselwitz B, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003;34:1099–1110.

    Article  Google Scholar 

  22. Goldstein L. North Carolina stroke prevention and treatment facilities survey. Stroke 2000;31:66–70.

    PubMed  CAS  Google Scholar 

  23. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM, for the Cleveland Clinic Health System Stroke Quality Improvement Team. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke 2003;34:799,800.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guntram W. Ickenstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ickenstein, G.W., Horn, M., Schenkel, J. et al. The use of telemedicine in combination with a new stroke-code-box significantly increases t-PA use in rural communities. Neurocrit Care 3, 27–32 (2005). https://doi.org/10.1385/NCC:3:1:027

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/NCC:3:1:027

Key Words

Navigation